Skip to main content
  •   

    Episode 297: Journal Club Including DRCR Protocol AG and AH, Post Hoc Analysis of Protocol AB and more

    Straight From the Cutter's Mouth
    01:05:51
    Retina/Vitreous
    CME 0.5 General AMA PRA Category 1 Credits™
    Add to My Bookmarks

    Drs. Avni Finn, Safa Rahmani, and Yoshihiro Yonekawa join for a journal club reviewing four recent publications in major ophthalmology journals:

    Relevant Financial Disclosures: Dr. Sridhar has consulted for Regeneron, Genentech, Alcon, Dorc, and Oxurion. Dr. Finn has consulted for Genentech and Allergan. Dr. Yonekawa has consulted for Alcon, Alimera, Allergan, and Genentech. Dr. Rahmani has no relevant disclosures.

    CME Information

    Release: June 7, 2021; expires June 7, 2024 

    Reviewer: Carl Danzig, MD

    Disclosures: The physician reviewers and Academy staff report no relevant financial disclosures.

    Learning Objective: Upon completion of this episode, the listener should be able to describe evolving standards of care for the management of vitreoretinal disorders or the outcomes from recent research and how these impact patient care decisions.

    Audience: This activity is intended for retina subspecialists and comprehensive ophthalmologists.

    Accreditation: The American Academy of Ophthalmology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The American Academy of Ophthalmology designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits.TM Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Hardware/Software Requirements: This learning activity requires a current web browser and speaker or headset capable of playing streaming audio.